Product Images Quetiapine Fumarate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Quetiapine Fumarate NDC 70518-0767 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Quetiapine 200mg 70518 0767 01

Quetiapine 200mg 70518 0767 01

Quetiapine is a tablet with a strength of 200 mg. The package contains 30 tablets and it was repackaged by RemedyRepack Inc. The product is only available with a prescription and has an NDC number of 70518-0767-01. The source NDC is 47335-0905-88 and it was manufactured by Sun Pharma in Cranbury, NJ. It should be stored at 20-25°C but excursions are allowed between 15-30°C. Directions for use can be found in the package insert, and caregivers are advised to keep it out of reach of children.*

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Quetiapine is a tablet with a strength of 200 mg. It comes in a pack of 30 tablets and is meant for prescription only. The manufacturer of the tablet is Sun Pharma located in Cranbury, NJ. The source NDC is 47335-0905-88 and the repackaging is done by RemedyRepack Inc. The tablets should be stored at a temperature range of 20-25°C or 15-30°C. A package insert should be referred to for directions. The lot number and expiry date are not available.*

quetiapine-fig-1 - quetiapine fig 1

quetiapine-fig-1 - quetiapine fig 1

quetiapine-fig-2 - quetiapine fig 2

quetiapine-fig-2 - quetiapine fig 2

The figure 2 displays the Kaplan-Meier curves illustrating the time to recurrence of a mood event for Study 8. The x-axis shows the time in weeks, while the y-axis shows the proportion of patients with relapse expressed as a percentage. The blue line represents patients treated with QTP+LIVAL, while the orange line represents patients treated with PLA+LIVAL. The figure suggests that patients treated with QTP+LIVAL had a lower proportion of relapse compared to those treated with PLA+LIVAL over a given period of time.*

quetiapine-structure - quetiapine structure

quetiapine-structure - quetiapine structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.